Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Northbaze Group | NBZ | Apr 22, 2024 | 0.35 | +0.57 |
Northern CapSek Ventures | CAPS | Apr 22, 2024 | 0.43 | +4.88 |
Northern CapSek Ventures PREF | CAPSPREF | Apr 22, 2024 | 0.70 | 0.00 |
Northgold | NG | Apr 22, 2024 | 3.48 | -2.79 |
Norva24 | NORVA | Apr 22, 2024 | 25.90 | -0.38 |
Nosa Plugs | NOSA | Apr 22, 2024 | 0.45 | -1.42 |
Nosium | NOSIUMB | Apr 22, 2024 | 0.01 | 0.00 |
Note | NOTE | Apr 22, 2024 | 127.70 | -1.92 |
Novotek B | NTEKB | Apr 22, 2024 | 60.40 | -2.89 |
Novus Group | NOVU | Apr 22, 2024 | 2.88 | -1.37 |
Nowonomics | NOWO | Apr 22, 2024 | 4.50 | +8.70 |
NP3 Fastigheter | NP3 | Apr 22, 2024 | 220.50 | +0.92 |
NP3 Fastigheter Pref | NP3PREF | Apr 22, 2024 | 29.00 | +0.87 |
Nyfosa | NYF | Apr 22, 2024 | 97.05 | +0.05 |
Nykode Therapeutics | NYKDO | Apr 22, 2024 | 13.05 | 0.00 |
Obducat B | OBDUB | Apr 22, 2024 | 1.72 | -0.87 |
Observit | OBSE | Apr 22, 2024 | 0.17 | -3.94 |
ODI Pharma | ODI | Apr 22, 2024 | 5.50 | +0.92 |
Odinwell | ODIN | Apr 22, 2024 | 0.60 | -3.97 |
OEM International B | OEMB | Apr 22, 2024 | 96.80 | -0.82 |
Ogunsen B | OGUNB | Apr 22, 2024 | 39.10 | -3.69 |
OmniCar | OMNI | Apr 22, 2024 | 0.06 | +19.60 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Apr 22, 2024 | 297.40 | +0.34 |
OMX NORDIC 40 | OMXN40 | Apr 22, 2024 | 2 732.36 | +0.85 |
OMX Oslo 20 GI | OMXO20GI | Apr 22, 2024 | 1 226.21 | -0.31 |
OMX Oslo 20 PI | OMXO20PI | Apr 22, 2024 | 707.07 | -0.31 |
OMX Stockholm 30 | OMXS30 | Apr 22, 2024 | 2 511.41 | +0.37 |
OMX Stockholm 30 GI | OMXS30GI | Apr 22, 2024 | 486.60 | +0.37 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Apr 22, 2024 | 306.36 | +0.40 |
OMX Stockholm 60 PI | OMXS60PI | Apr 22, 2024 | 287.79 | +0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.